Literature DB >> 19007016

[Effect and mechanism on dopamine contents of striatum in rat model of Parkinson's disease ginsenoside Rg1].

Li Xu1, Li-xing Liu, Wen-fang Chen.   

Abstract

OBJECTIVE: To investigate effect and mechanisms on dopamine contents of striatum (Str) in the 6-OHDA induced rat model of Parkinson's disease (PD) by ginsenoside Rg1.
METHOD: Ovariectomized PD rats were treated with vehicle, ginsenoside Rg1, (10 mg x kg(-1)) or estrogen receptor (ER) antagonist ICI 182,780 for 14 d. The change of apomorphine-linduced rotational behavior in PD rats were observed. The high performance lipid chromotophotography (HPLC) was used to determine the contents of DA, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA)in striatum. RESULT: Rg1 treatment could ameliorate the PD rat's rotational behavior induced by apomorphine (P < 0.01). This effect could be blocked by ER antagonist ICI 182,780. The DA, DOPAC and HVA levels in the injured side of Str for PD rats were significantly decreased compared with the intact side (P < 0.01). Rg1, treatment could increase DA contents in the injured side of Str (P < 0.01). ICI 182,780 could completely block the neuroprotective effects of Rg1. The DA contents and its metabolites in the injured side of the ICI treatment group were significantly decreased compared with the Rg1 group (P < 0.01).
CONCLUSION: Ginsenoside Rg1 may have protective effects on the dopaminergic neurons for the 6-OHDA induced OVX rat model of PD, ER. May be involved in the protection action.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19007016

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

Review 1.  A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease.

Authors:  Liang Song; Meng-Bei Xu; Xiao-Li Zhou; Dao-Pei Zhang; Shu-Ling Zhang; Guo-Qing Zheng
Journal:  Oxid Med Cell Longev       Date:  2017-03-13       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.